Effects of the RAF/MEK/ERK and PI3k/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells

Oncogene

Volumn 22, Issue 16, 2003, Pages 2478-2492

  Shelton, John G ^a   Steelman, Linda S ^a   Lee, John T ^a   Knapp, Steven L ^a   Blalock, William L ^a   Moye, Phillip W ^a   Franklin, Richard A ^a   Pohnert, Steven C ^a   Mirza, Amer M ^b   McMahon, Martin ^b   McCubrey, James A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Akt; Annexin V binding; Apoptosis; Autocrine transformation; Cytokine dependence; Hematopoietic cells; P13K; Raf; Signal transduction

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYTOKINE; PROTEIN KINASE B; RAF PROTEIN; UO 126;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL DEATH; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; CELL PROTECTION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA SYNTHESIS; EVALUATION; GENE EXPRESSION; HEMATOPOIETIC CELL; LEUKEMOGENESIS; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CELL DIVISION; CYTOKINES; HEMATOPOIETIC STEM CELLS; MAP KINASE KINASE KINASE 1; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-RAF; SIGNAL TRANSDUCTION; TESTOSTERONE;

ANIMALIA;

EID: 0038476605     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206321     Document Type: Article

References (68)

1. Blalock WL, Moye PW, Chang F, Pearce M, Steelman LS, McMahon M and McCubrey JA. (2000b). Leukemia, 14, 1080-1096.
2. Blalock WL, Pearce M, Chang F, Lee J, Pohnert S, Burrows C, Steelman LS, Franklin RA, McMahon M and McCubrey J. (2001). Leukemia, 15, 794-807.
3. Blalock WL, Pearce M, Steelman LS, Franklin RA, McCarthy SA, Cherwinski H, McMahon M and McCubrey JA. (2000a). Oncogene, 19, 526-536.
4. Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA, Franklin RA, Oberhaus SM, Steelman LS and McCubrey JA. (1999). Leukemia, 13, 1109-1166.
5. Bosch E, Cherwinski H, Peterson D and McMahon M. (1997). Oncogene, 11, 1021-1034.
6. Carroll MP and May WS. (1994). J. Biol. Chem., 269, 1249-1256.
7. Chang F and McCubrey JA. (2001). Oncogene, 20, 4353-4364.
8. Chang F, Steelman LS and McCubrey JA. (2002). Cell Cycle, 1, 220-227.
9. Chaudhary A, King WG, Mattaliano MD, Frost JA, Diaz B, Morrison DK, Cobb MH, Marshall MS and Brugge JS. (2000). Curr. Biol., 10, 551-554.
10. Clark SS, McLaughin J, Timmons M, Pendergast AM, Ben-Neriah Y, Dow LW, Crist W, Rovera G, Smith SD and Witte ON. (1988). Science, 239, 775-777.
11. Craddock BL and Welham MJ. (1997). J. Biol. Chem., 272, 29281-29289.
12. Dhillon AS, Meikle S, Yazici Z, Eulitz M and Kolch W. (2002a). EMBO J., 21, 64-71.
13. Dhillon AS, Pollock C, Steen H, Shaw PE, Mischak H and Kolch W. (2002b). Mol. Cell. Biol., 22, 3237-3246.
14. Duronio V, Scheid MP and Ettinger S. (1998). Cell. Signal. 10, 233-239.
15. Eychene A, Dusanter-Fourt I, Barnier JV, Papin C, Charon M, Gisselbrecht S and Calothy G. (1995). Oncogene, 10, 1159-1165.
16. Gelfanov VM, Burgess GS, Litz-Jackson S, King AJ, Marshall MS, Nakshatri H and Boswell HS. (2001). Blood, 15, 2508-2517.
17. Guan K, Figueroa C, Brtva TR, Zhu T, Taylor J, Barber TD and Vojtek AB. (2000). J. Biol. Chem., 275, 27354-27359.
18. Hoyle PE, Moye PW, Steelman LS, Blalock WL, Franklin RA, Pearce M, Cherwinski H, Bosch E, McMahon M and McCubrey JA. (2000). Leukemia, 14, 642-656.
19. Kaleko M, Rutter WJ and Miller AD. (1990). Mol. Cell. Biol., 10, 464-473.
20. Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L, Wigler MH and Der CJ. (1996). Mol. Cell. Biol., 16, 3923-3933.
21. Kohn D, Takeuchi F and Roth RA. (1996). J. Biol. Chem., 271, 21920-21926.
22. Kubota Y, Angelotti T, Niederfellner G, Herbst R and Ullrich A. (1998). Cell Growth Differ., 9, 247-256.
23. Lloyd AC, Obermuller F, Staddon S, Barth CF, McMahon M and Land H. (1997). Genes Dev., 11, 663-677.
24. Majewski M, Nieborowska-Skorska M, Salomoni P, Slupianek A, Reiss K, Trotta R, Calabretta B and Skorski T. (1999). Cancer Res., 59, 2815-2819.
25. Marais R, Light Y, Paterson HF and Marshall CJ. (1995). EMBO J., 14, 3136-3145.
26. Marshall M. (1995). Mol. Reprod. Dev., 42, 493-499.
27. McCubrey JA, Blalock WL, Chang F, Steelman LS, Pohnert SC, Navolanic PM, Shelton JG, Hoyle PE, Moye PW, Oberhaus SM, White MK, Lee JI and Franklin RA (2001d). Cell Cycle Checkpoints and Cancer. Blagosklonny M. (ed). Landes Bioscience Press: Austin, TX, pp. 17-51.
28. McCubrey J, Holland G, McKearn J and Risser R. (1989). Oncogene Res., 4, 97-109.
29. McCubrey JA, Lee JT, Steelman LS, Blalock WL, Moye PW, Chang F, Pearce M, Shelton JG, White MK, Franklin RA and Pohnert SC. (2001a). Cancer Detect. Prevent., 25, 375-393.
30. McCubrey JA, May WS, Duronio V and Mufson A. (2000a). Leukemia, 14, 9-21.
31. McCubrey JA, Steelman LS, Blalock WL, Lee JT, Moye PW, Chang F, Pearce M, Shelton JG, White MK, Franklin RA and Pohnert SC. (2001b). Adv. Enzyme Regul., 41, 289-323.
32. McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA, Cherwinski H, Bosch E and McMahon M. (1998). Leukemia, 12, 1903-1929.
33. McCubrey JA, Steelman LS, Mayo MW, Algate PA, Dellow RA and Kaleko M. (1991). Blood, 78, 921-929.
34. McCubrey JA, Steelman LS, Moye PW, Hoyle PE, Weinstein-Oppenheimer C, Chang F, Pierce M, White MK, Franklin R and Blalock WL. (2000b). Adv. Enzyme Regul., 40, 305-337.
35. McCubrey JA, Wang XY, Algate PA, Blalock WL and Steelman LS. (2001c). Cell Cycle Checkpoints and Cancer. Blagosklonny M. (ed) Landes Bioscience Press Austin, TX, pp. 1-16.
36. McIlroy J, Chen D, Wjasow C, Michaeli T and Backer JM. (1997). Mol. Cell. Biol. 17, 248-255.
37. McKearn JP, McCubrey JA and Fagg B. (1985). Proc. Natl. Acad. Sci. USA, 85, 7414-7418.
38. McMahon M. (2001). Methods Enzymol., 332, 401-417.
39. Minshall C, Arkins S, Freund GG and Kelly KW. (1996). J. Immunol., 156, 939-947.
40. Mischak H, Seitz T, Janosch P, Eulitz M, Steen H, Schellerer M, Philipp A and Kolch W. (1996). Mol. Cell. Biol., 16, 5409-5418.
41. Mizra A, Kohn AD, Roth RA and McMahon. (2000). Cell Growth Diff., 11, 279-292.
42. Mizutani S, Inouye K, Koide K and Kaziro Y (2001). FEBS Lett., 507, 295-298.
43. Morgenstern JP and Land H. (1990). Nucleic Acids Res., 18, 3587-3596.
44. Moye PW, Blalock WL, Hoyle PE, Chang F, Franklin RA, Weinstein-Oppenheimer C, Pearce M, Steelman L, McMahon M and McCubrey JA. (2000). Leukemia, 14, 1060-1079.
45. Rapp UR, Huleihel M, Pawson T, Linnoila I, Minna JD, Heidecker G, Cleveland JL, Beck T, Forchhammer J and Storm SM. (1988). Lung Cancer, 4, 162-167.
46. Rodriguez-Viciana P, Marte BM, Warne PH and Downward J. (1996). Philos. Trans. Roy. Soc. London Series B: Biol. Sci., 351, 225-231.
47. Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, Waterfield MD and Downward J. (1996). EMBO J., 15, 2442-2451.
48. Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A and Downward J. (1997). Cell, 89, 457-467.
49. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD and Glass DJ. (1999). Science, 286, 1738-1741.
50. Samuels ML, Weber MJ, Bishop JM and McMahon M (1993). Mol. Cell. Biol., 13, 6241-6252.
51. Scheid MP and Duronio V. (1998). Proc. Natl. Acad. Sci. USA, 95, 7439-7444.
52. Scheid MP and Woodgett JR. (2001). Nat. Rev. Mol. Cell. Biol., 2, 760-768.
53. Storm SM and Rapp UR: (1993). Toxicol. Lett., 67, 201-210.
54. Sutor SL, Vroman BT, Armstrong EA, Abraham RT and Karnitz LM. (1999). J. Biol. Chem., 274, 7002-7010.
55. Tan Y, Ruan H, Demeter MR and Comb MJ. (1999). J. Biol. Chem., 274, 34859-34867.
56. Vanhaesebroeck B, Leevers SJ, Panayotou G and Waterfield MD. (1997). Trends Biochem. Sci., 22, 267-272.
57. von Gise A, Lorenz P, Wellbrock C, Hemmings B, Berberich-Siebelt F, Rapp UR and Troppmair J. (2001). Mol. Cell. Biol., 21, 2324-2336.
58. Weber CK, Slupsky JR, Kalmes HA and Rapp UR. (2001). Cancer Res., 61, 3595-3598.
59. Weinstein-Oppenheimer CR, Blalock WL, Steelman LS, Chang F and McCubrey JA. (2000b). Pharmacol. Therap., 88, 230-279.
60. Weinstein-Oppenheimer C, Steelman LS, Algate PA, Blalock WL, Burrows C, Hoyle PE, Lee JT, Moye PW, Shelton JG, Franklin RA and McCubrey JA. (2000a). Leukemia, 14, 1921-1938.
61. Wick MJ, Dong LQ, Riojas RA, Ramos FJ and Liu F. (2000). J. Biol. Chem., 275, 40400-40406.
62. Williams MR, Arthur JS, Balendran A, van der Kaay J, Poli V, Cohen P and Alessi DR. (2000). Curr. Biol., 10, 439-448.
63. Woods D, Parry D, Cherwinski H, Bosch E, Lees E and McMahon M. (1997). Mol. Cell. Biol., 17, 5598-5611.
64. Xing J, Ginty DD and Greenberg ME. (1996). Science, 273, 959-963.
65. Yan J, Roy S, Apolloni A, Lane A and Hancock JF. (1998). J. Biol. Chem., 273, 24052-24056.
66. Zhang BH, Tang E, Zhu T, Greenberg M, Vojtek A and Guan KL. (2001). J. Biol. Chem., 276, 31620-31626.
67. Zhou X, Liu Y, Payne G, Lutz RJ and Chittenden T. (2000). J. Biol. Chem., 275, 25046-25051.
68. Zimmermann S and Moelling K. (1999). Science, 286, 1741-1744.